MedPath

To Study the Potential role of drug Hyrdoxyurea in Thalassemia in reducing the burden of frequent blood transfusion in children of Southern Rajastha

Phase 3
Conditions
Health Condition 1: D561- Beta thalassemia
Registration Number
CTRI/2024/08/071925
Lead Sponsor
RNT Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All Known case of Beta Thallasemia Major less than 18 years of age visiting Thalassemia Day Care Centre for regular Blood Transfusion/Followup

Exclusion Criteria

Children having other causes of Anemia,Pre- exisitng Renal disease ,Pre- existing hepatic disease, Thromboctyopenia, Neutropenia, children having Chronic hepatitis B,C HIV ,HBsAg seropositivity,Not giving Informed consent were excluded from this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath